Fierlbeck G - Search Results

1

Efficacy of pulsed intravenous immunoglobulin therapy in mixed connective tissue disease.

Ulmer A, Kötter I, Pfaff A, Fierlbeck G. Ulmer A, et al. Among authors: fierlbeck g. J Am Acad Dermatol. 2002 Jan;46(1):123-7. doi: 10.1067/mjd.2001.118539. J Am Acad Dermatol. 2002. PMID: 11756958

2

Response of dystrophic calcification to intravenous immunoglobulin.

Schanz S, Ulmer A, Fierlbeck G. Schanz S, et al. Among authors: fierlbeck g. Arch Dermatol. 2008 May;144(5):585-7. doi: 10.1001/archderm.144.5.585. Arch Dermatol. 2008. PMID: 18490584 No abstract available.

3

Images in clinical medicine. Oral manifestations of secondary syphilis.

Ulmer A, Fierlbeck G. Ulmer A, et al. Among authors: fierlbeck g. N Engl J Med. 2002 Nov 21;347(21):1677. doi: 10.1056/NEJMicm020403. N Engl J Med. 2002. PMID: 12444182 Free article. No abstract available.

4

Ulcerated epithelioid hemangioendothelioma of the foot in childhood.

Forschner A, Harms D, Metzler G, Sönnichsen K, Ulmer A, Rassner G, Fierlbeck G. Forschner A, et al. Among authors: fierlbeck g. J Am Acad Dermatol. 2003 Jul;49(1):113-6. doi: 10.1067/mjd.2003.416. J Am Acad Dermatol. 2003. PMID: 12833020

5

Intravenous immunoglobulin in livedo vasculitis: a new treatment option?

Schanz S, Ulmer A, Fierlbeck G. Schanz S, et al. Among authors: fierlbeck g. J Am Acad Dermatol. 2003 Sep;49(3):555-6. doi: 10.1067/s0190-9622(03)00785-0. J Am Acad Dermatol. 2003. PMID: 12963934 No abstract available.

6

Suppression of melanoma-associated neoangiogenesis by bevacizumab.

Jaissle GB, Ulmer A, Henke-Fahle S, Fierlbeck G, Bartz-Schmidt KU, Szurman P. Jaissle GB, et al. Among authors: fierlbeck g. Arch Dermatol. 2008 Apr;144(4):525-7. doi: 10.1001/archdermatol.2007.38. Arch Dermatol. 2008. PMID: 18427047

7

Interstitial granulomatous dermatitis with arthritis responding to tocilizumab.

Schanz S, Schmalzing M, Guenova E, Metzler G, Ulmer A, Kötter I, Fierlbeck G. Schanz S, et al. Among authors: fierlbeck g. Arch Dermatol. 2012 Jan;148(1):17-20. doi: 10.1001/archdermatol.2011.341. Arch Dermatol. 2012. PMID: 22250229 No abstract available.

8

Treatment of pyoderma gangrenosum with topical factor XIII.

Hoetzenecker W, Guenova E, Mitev V, Schanz S, Ulmer A, Fierlbeck G. Hoetzenecker W, et al. Among authors: fierlbeck g. Eur J Dermatol. 2013 Sep-Oct;23(5):653-7. doi: 10.1684/ejd.2013.2147. Eur J Dermatol. 2013. PMID: 24135449

9

Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.

Schanz S, Ulmer A, Rassner G, Fierlbeck G. Schanz S, et al. Among authors: fierlbeck g. Br J Dermatol. 2002 Jul;147(1):174-8. doi: 10.1046/j.1365-2133.2002.04875.x. Br J Dermatol. 2002. PMID: 12100205

10

Successful palliation of stenosing anorectal melanoma by intratumoral injections with natural interferon-beta.

Ulmer A, Metzger S, Fierlbeck G. Ulmer A, et al. Among authors: fierlbeck g. Melanoma Res. 2002 Aug;12(4):395-8. doi: 10.1097/00008390-200208000-00013. Melanoma Res. 2002. PMID: 12170190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters